G1 Therapeutics Inc (GTHX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -73,907 | -62,233 | -31,023 | -122,447 | -87,006 |
| Depreciation Amortization | 813 | 405 | 159 | 356 | 215 |
| Other Working Capital | 7,306 | -2,398 | -896 | 6,071 | 5,245 |
| Other Operating Activity | 13,554 | 8,353 | 4,735 | 16,449 | 11,986 |
| Operating Cash Flow | $-52,234 | $-55,873 | $-27,025 | $-99,571 | $-69,560 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 152 | N/A | N/A | -2,716 | -1,616 |
| Investing Cash Flow | $152 | $N/A | $N/A | $-2,716 | $-1,616 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 20,000 | 20,000 | N/A | N/A | N/A |
| Common Stock Issued | 1,836 | 1,457 | 219 | 2,705 | 2,319 |
| Other Financing Activity | -620 | -525 | 0 | 0 | 0 |
| Financing Cash Flow | $21,216 | $20,932 | $219 | $2,705 | $2,319 |
| Beginning Cash Position | 269,708 | 269,708 | 269,708 | 369,290 | 369,290 |
| End Cash Position | 238,842 | 234,767 | 242,902 | 269,708 | 300,433 |
| Net Cash Flow | $-30,866 | $-34,941 | $-26,806 | $-99,582 | $-68,857 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,234 | -55,873 | -27,025 | -99,571 | -69,560 |
| Capital Expenditure | N/A | N/A | N/A | -2,716 | -1,616 |
| Free Cash Flow | -52,234 | -55,873 | -27,025 | -102,287 | -71,176 |